Supply Chain
Long wait times, crowded waiting rooms, and frustrated staff are often symptoms of inefficient workflows driven by physical space constraints.…
Michael Laufer, PhD, a college professor and leader in the growing biohacker movement, wants to teach patients how to make their own medications to subvert the drug industry's high prices, according to STAT.
Here are six drug and medical device companies that made headlines in the past week.
Roche formed a strategic collaboration with the drug discovery company Warp Drive Bio to develop new classes of antibiotics.
The Food and Drug Administration on Friday expanded the approval for Johnson & Johnson's psoriasis drug Stelara.
The FDA approved a new robotically- assisted surgical device, Senhance System, to facilitate minimally invasive surgeries.
Baxter International anticipates a temporary shortage of small saline IV bags in the U.S. due to manufacturing issues in hurricane-damaged Puerto Rico, reports USA Today.
Here are the four latest drugs and medical devices approved by the Food and Drug Administration in the past week.
Investment and startup activity in the medical technology sector is in decline, according to a joint report from Deloitte and AdvaMed.
The FDA approved a record-breaking number of generic drugs in fiscal year 2017.
In an era of increasing uncertainty and rising pressures in healthcare, many health systems are discovering the benefits of getting everybody involved in improving the supply chain. In a complex healthcare system, there is no single “root cause” behind overall…
Mark Graban